Use of tigecycline at a teaching hospital

Use of tigecycline at a teaching hospital Gleycivane Nunes da Silva, Erivaldo Elias Junior, Vanessa Marcon de Oliveira, Erica Freire de Vasconcelos Pereira, Cristiane Munaretto Ferreira, Bianca Rodrigues Acacio, Vanessa Terezinha Gubert, Maria Tereza Ferreira Duenhas Monreal Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas, Nutrição e Alimentação, Universidade Federal de Mato Grosso do Sul (UFMS) – Campo Grande (MS), Brazil Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, UFMS – Campo Grande (MS), Brazil Farmácia Escola Profa Ana Maria Cervantes Baraza, Faculdade de Ciências Farmacêuticas, Nutrição e Alimentação, UFMS – Campo Grande (MS), Brazil

[1]  Ya-ping Pan,et al.  The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis , 2017, Annals of Clinical Microbiology and Antimicrobials.

[2]  F. J. Martín-Sánchez,et al.  Efecto de la inadecuación de la antibioterapia en Urgencias sobre la eficiencia en la hospitalización , 2017 .

[3]  S. Salso,et al.  [Tigecycline: 10 years of history and still in full force]. , 2015, Revista Espanola de Quimioterapia.

[4]  E. Alp,et al.  Increasing frequency of Pseudomonas aeruginosa infections during tigecycline use. , 2015, Journal of infection in developing countries.

[5]  W. Heizmann,et al.  Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria , 2014, Infection.

[6]  H. Dupont,et al.  Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting , 2014, Intensive Care Medicine.

[7]  M. Bassetti,et al.  Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies. , 2013, The Journal of antimicrobial chemotherapy.

[8]  M. Bassetti,et al.  Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. , 2013, The Journal of antimicrobial chemotherapy.

[9]  A. Omrani,et al.  Prevalence of colistin and tigecycline resistance in Acinetobacter baumannii clinical isolates from 2 hospitals in Riyadh Region over a 2-year period. , 2013, Saudi medical journal.

[10]  M. Bassetti,et al.  Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies. , 2013, The Journal of antimicrobial chemotherapy.

[11]  M. Shorman,et al.  In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia , 2012, Journal of chemotherapy.

[12]  L. Leibovici,et al.  Efficacy and safety of tigecycline: a systematic review and meta-analysis. , 2011, The Journal of antimicrobial chemotherapy.

[13]  F. Rossi.  The challenges of antimicrobial resistance in Brazil. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Ugarte Ubiergo,et al.  Tigecycline treatment of critically ill patients: the LatinUser experience. , 2011, Current Clinical Pharmacology.

[15]  M. Bassetti,et al.  Tigecycline use in serious nosocomial infections: a drug use evaluation , 2010, BMC infectious diseases.

[16]  S. Luque,et al.  [Differences in the use of tigecycline between ICU patients and non-ICU patients]. , 2010, Revista Espanola de Quimioterapia.

[17]  D. Curcio,et al.  Prescription of Antibiotics in Intensive Care Units in Latin America: An Observational Study , 2009, Journal of chemotherapy.

[18]  F. Fernández,et al.  Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry. , 2008, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[19]  F. Fernández,et al.  [Initial use of tigecycline in Argentina]. , 2007, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

[20]  R. Ward,et al.  Off‐label use of medicines: consensus recommendations for evaluating appropriateness , 2006, The Medical journal of Australia.